Search by Drug Name or NDC

    NDC 00310-6530-04 BYDUREON 2 mg/.65mL Details

    BYDUREON 2 mg/.65mL

    BYDUREON is a SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is EXENATIDE.

    Product Information

    NDC 00310-6530
    Product ID 0310-6530_4657408e-58a8-4d73-85e4-a39a281786e7
    Associated GPIs 2717002000D120
    GCN Sequence Number 072230
    GCN Sequence Number Description exenatide microspheres PEN INJCTR 2MG/0.65ML SUBCUT
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 36352
    HICL Sequence Number 038451
    HICL Sequence Number Description EXENATIDE MICROSPHERES
    Brand/Generic Brand
    Proprietary Name BYDUREON
    Proprietary Name Suffix n/a
    Non-Proprietary Name exenatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION, EXTENDED RELEASE
    Route SUBCUTANEOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/.65mL
    Substance Name EXENATIDE
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022200
    Listing Certified Through n/a

    Package

    NDC 00310-6530-04 (00310653004)

    NDC Package Code 0310-6530-04
    Billing NDC 00310653004
    Package 1 TRAY in 1 CARTON (0310-6530-04) / 4 CARTRIDGE in 1 TRAY / .65 mL in 1 CARTRIDGE
    Marketing Start Date 2014-09-08
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 181.566
    Pricing Unit EA
    Effective Date 2022-01-19
    NDC Description BYDUREON 2 MG PEN INJECT
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting B
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis